Target Details
| UniProt AC | P49841 |
|---|---|
| Gene Symbol | GSK3B |
| Protein Name | Glycogen synthase kinase-3 beta |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF00069 (Pkinase) |
Summary
- Multi-target molecules 2,206
- Clinical molecules 168
- Avg pChEMBL 7.19
KEGG Pathways (49)
- Alcoholic liver disease
- Alzheimer disease
- Axon guidance
- B cell receptor signaling pathway
- Basal cell carcinoma
- Breast cancer
- Cadherin signaling
- Cell cycle
- Chemokine signaling pathway
- Colorectal cancer
- Cushing syndrome
- Diabetic cardiomyopathy
- Dopaminergic synapse
- EGFR tyrosine kinase inhibitor resistance
- Endometrial cancer
- ErbB signaling pathway
- Focal adhesion
- Gastric cancer
- Growth hormone synthesis, secretion and action
- Hedgehog signaling pathway
- Hepatitis C
- Hepatocellular carcinoma
- Hippo signaling pathway
- Human cytomegalovirus infection
- Human papillomavirus infection
- IL-17 signaling pathway
- IgSF CAM signaling
- Insulin resistance
- Insulin signaling pathway
- Integrin signaling
- Kaposi sarcoma-associated herpesvirus infection
- Lipid and atherosclerosis
- Measles
- Melanogenesis
- Neurotrophin signaling pathway
- Non-alcoholic fatty liver disease
- PI3K-Akt signaling pathway
- Pathways in cancer
- Pathways of neurodegeneration - multiple diseases
- Prion disease
- Prolactin signaling pathway
- Prostate cancer
- Shigellosis
- Signaling pathways regulating pluripotency of stem cells
- T cell receptor signaling pathway
- Thyroid hormone signaling pathway
- Wnt signaling pathway
- Yersinia infection
- mTOR signaling pathway
Active Molecules (2,206)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
PYGXLJHSRXXLTK
|
6.3 | IC50 | 2 | — | |
PYYNSFKCZSHTKG
|
6.3 | IC50 | 2 | — | |
QBBQFIGFJYZYKJ
|
6.3 | IC50 | 2 | — | |
QDTZQTWMFWPRKB
|
6.3 | IC50 | 2 | — | |
QEMJZLIXMCCJSF
|
6.3 | IC50 | 2 | — | |
QKABCCIZUZNYKM
|
6.3 | IC50 | 2 | — | |
QLTSLQGBAKVJRT
|
6.3 | IC50 | 2 | — | |
QOZMRRGNAZNWDN
|
6.3 | IC50 | 2 | — | |
QTQMVQZYHISBBL
|
6.3 | IC50 | 2 | — | |
QTQMVQZYHISBBL
|
6.3 | IC50 | 2 | — | |
QZULDCGSKLHYGD
|
6.3 | IC50 | 2 | — | |
RFZOFAUMLCFXEK
|
6.3 | IC50 | 2 | — | |
RGAPGOMQMSFQCX
|
6.3 | IC50 | 2 | — | |
RGCDYOXTXJGPLM
|
6.3 | IC50 | 2 | — | |
RKNUAJQNWXJZGZ
|
6.3 | IC50 | 2 | — | |
RKNUAJQNWXJZGZ
|
6.3 | IC50 | 2 | — | |
RLTHFXLOMYPTFD
|
6.3 | IC50 | 2 | — | |
RPQYOMSBVPFFBS
|
6.3 | IC50 | 2 | — | |
RSIVPCVBMLDYJD
|
6.3 | IC50 | 2 | — | |
RTGXNRPXVMQKFH
|
6.3 | IC50 | 2 | — | |
RXVQGGQKYSYSJS
|
6.3 | IC50 | 2 | — | |
SAOTVLLAHJNENQ
|
6.3 | IC50 | 2 | — | |
SGYYHJQKAWUXAU
|
6.3 | IC50 | 2 | — | |
SLEGGYULIMKYQA
|
6.3 | IC50 | 2 | — | |
STHZOMIQANTSLT
|
6.3 | IC50 | 2 | — | |
SWUMXOGIHPAPBI
|
6.3 | IC50 | 2 | — | |
TWWOJDYFXVLZHX
|
6.3 | IC50 | 2 | — | |
TWWOJDYFXVLZHX
|
6.3 | IC50 | 2 | — | |
TXDQGBBBTIUCBD
|
6.3 | IC50 | 2 | — | |
TXEGTNYNZRIZPA
|
6.3 | IC50 | 2 | — | |
TYYMYGWTBNTQHZ
|
6.3 | IC50 | 2 | — | |
UBLTWZMQSVOIMC
|
6.3 | IC50 | 2 | — | |
UGXIUFYOMAZQEN
|
6.3 | IC50 | 2 | — | |
UNKZLWPZUIVEET
|
6.3 | IC50 | 2 | — | |
UPUMMBDWBYOWND
|
6.3 | IC50 | 2 | — | |
UQCXRZPQXXKDPY
|
6.3 | IC50 | 2 | — | |
USHQHWWKKUUIKX
|
6.3 | IC50 | 2 | — | |
USZASPUPZOUPLU
|
6.3 | IC50 | 2 | — | |
UTIMWVJWFDKCDP
|
6.3 | IC50 | 2 | — | |
UTTVUJAMJNTDNA
|
6.3 | IC50 | 2 | — | |
UUWWOCIFRLZETB
|
6.3 | IC50 | 2 | — | |
UVIDXGSIQGUTJO
|
6.3 | IC50 | 2 | — | |
UVQHZVRLYTUTHD
|
6.3 | IC50 | 2 | — | |
UWSSSWNECZPFPM
|
6.3 | IC50 | 2 | — | |
VBEWEBIGJADYRH
|
6.3 | IC50 | 2 | — | |
VGNLWHIUTMPUDP
|
6.3 | IC50 | 2 | — | |
VJBMRGLNRWUPSS
|
6.3 | IC50 | 2 | — | |
VNXBCPQQIZBCFD
|
6.3 | IC50 | 2 | — | |
VPRXHCBUPYMFPV
|
6.3 | IC50 | 2 | — | |
VXFCJWJLGJKYAJ
|
6.3 | IC50 | 2 | — |